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Abstract
Background: Dysregulation of monocyte-macrophage differentiation is a hallmark of vascular and metabolic diseases and
associated with persistent low grade inflammation. Plasmalogens represent ether lipids that play a role in diabesity and
previous data show diminished plasmalogen levels in obese subjects. We therefore analyzed transcriptomic and lipidomic
changes during monocyte-macrophage differentiation in vitro using a bioinformatic approach.
Methods: Elutriated monocytes from 13 healthy donors were differentiated in vitro to macrophages using rhM-CSF under
serum-free conditions. Samples were taken on days 0, 1, 4 and 5 and analyzed for their lipidomic and transcriptomic profiles.
Results: Gene expression analysis showed strong regulation of lipidome-related transcripts. Enzymes involved in fatty acid
desaturation and elongation were increasingly expressed, peroxisomal and ER stress related genes were induced. Total
plasmalogen levels remained unchanged, while the PE plasmalogen species pattern became more similar to circulating
granulocytes, showing decreases in PUFA and increases in MUFA. A partial least squares discriminant analysis (PLS/DA)
revealed that PE plasmalogens discriminate the stage of monocyte-derived macrophage differentiation. Partial correlation
analysis could predict novel potential key nodes including DOCK1, PDK4, GNPTAB and FAM126A that might be involved in
regulating lipid and especially plasmalogen homeostasis during differentiation. An in silico transcription analysis of lipid
related regulation revealed known motifs such as PPAR-gamma and KLF4 as well as novel candidates such as NFY, RNF96
and Zinc-finger proteins.
Conclusion: Monocyte to macrophage differentiation goes along with profound changes in the lipid-related transcriptome.
This leads to an induction of fatty-acid desaturation and elongation. In their PE-plasmalogen profile macrophages become
more similar to granulocytes than monocytes, indicating terminal phagocytic differentiation. Therefore PE plasmalogens
may represent potential biomarkers for cell activation. For the underlying transcriptional network we were able to predict a
range of novel central key nodes and underlying transcription factors using a bioinformatic approach.
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Introduction
Macrophages are key players in innate immunity and play an
important role in the development of atherosclerosis and insulin
resistance in diabesity [1]. During atherogenesis, modified ApoB
containing lipoproteins accumulate in atherosclerotic plaques and
lead to chemotaxis and accumulation of monocytes in the
subintima [1]. Under the pro-inflammatory influence of the local
microenvironment these monocytes terminally differentiate to M1
or M2 macrophages or antigen presenting cells (APC) [2–4].
During early lesion growth macrophages develop resistance to
apoptosis and oxidative stress, whereas in advanced lesions
macrophage death contributes to the formation of a necrotic core
[5]. Consequently metabolic syndrome correlates with persistent
low grade inflammation as indicated by increased serum levels of
IL-6, CRP and fibrinogen [6]. Moreover metabolic overload
induces an ER-stress response and leads to the formation of
reactive oxygen species (ROS) [7].
Lipids regulate biological processes either locally as membrane
components or remotely as signaling molecules. The lipid
composition of the plasma membrane determines membrane
fluidity but direct lipid-protein interactions also play a role in
cellular signaling [8–10]. Moreover the release of signaling lipids
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from intracellular or membrane sources fulfills an important
function in inflammatory signaling [11]. In this context especially
eicosanoids, sphingosine-1-phosphate and lysophosphatidic acid
are worth mentioning. Plasmalogens are a group of lipids that play
a role in most of these tasks. In the plasma membrane they
regulate membrane fluidity, via their vinyl-ether bond in sn-1 they
act as anti-oxidants and in sn-2 position they carry the precursor
residues for n-3 and n-6 prostanoid synthesis. Interestingly
cleavage of this esther-bound alkyl chain is catalyzed by
plasmalogen-selective phospholipase A2 (PLA2) [11]. In circulat-
ing monocytes plasmalogens represent around 15% of all cellular
lipids [12]. They have also been shown to possess clinically
significant correlations to vascular, metabolic and neurodegener-
ative diseases [13]. For example lower levels of plasmalogens were
found in hypertensive patients and during aging in the aorta (even
more pronounced in atherosclerotic aortas) [6,14]. Similarly
plasmalogen depletion in red blood cell membranes has been
proposed as a marker for oxidative stress and membrane rigidity
and was suggested to be predictive for cardiovascular mortality
[15]. Under these conditions plasmalogens may exert a scavenger
function for reactive oxygen species in membranes, that could play
a role during the ER stress response. On the other hand
plasmalogen oxidation products such as alpha-hydroxyaldehydes
and plasmalogen epoxides were found to accumulate in athero-
sclerotic lesions [16].
In a previous study we could demonstrate that a SREBP1
dependent induction of monocyte fatty acid synthesis is vital for
monocyte-macrophage differentiation [17]. Detailed analysis of
the changes in plasmalogen species and the underlying regulation
might therefore provide further insight into the role of this specific
lipid classe in the differentiation process. Recent advances in mass
spectrometry made high-throughput analysis of plasmalogen
species feasible for use in research and in the clinical routine
laboratory [18]. This technology allows to follow the regulation of
individual species and analysis of regulatory patterns that might
reflect pathophysiological adaptations in atherosclerotic lesions.
The aim of the current study was therefore to analyze in detail the
transcriptomic and lipidomic alterations during the course of
monocyte-macrophage differentiation and to evaluate the poten-
tial of plasmalogens as marker lipids for differentiation of
monocytes to inflammatory macrophages. A bioinformatic
approach was used to examine the underlying transcriptional
regulation and to reverse engineer gene regulatory networks to
identify potential novel key nodes.
Materials and Methods
Materials
If not otherwise stated all materials including 1a,25-dihydrox-
yvitamin D3 (VitD3), all2trans2retinoic acid (ATRA) and ethanol
were obtained from Sigma (Germany). Carrier-free macrophage
colony-stimulating factor (M-CSF) and granulocyte macrophage
colony-stimulating factor (GM-CSF) were both from R&D
systems. HPLC grade methanol and chloroform were from Merck
(Germany), plasmalogen standards from Avanti Polar Lipids
(Alabaster, AL, USA).
Figure 1. Gene ontology (GO) enrichment analysis of primary monocyte-macrophage differentiation. Normalized enrichment scores
(NES) indicate the distribution of Gene Ontology categories across a list of genes ranked by hypergeometrical score (HGS). Higher enrichment scores
indicate a shift of genes belonging to certain GO categories towards either end of the ranked list, representing up or down regulation (positive or
negative values, respectively). Lipid related catergories are generally found to be shifted upwards.
doi:10.1371/journal.pone.0094102.g001
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Blood cell isolation and in vitro differentiation of human
monocytes
Blood samples were obtained from thirteen healthy normolipi-
demic volunteers recruited from blood donors with apoE3/E3
genotype. Informed consent and approval of the Hospital Ethics
Committee were obtained (Universita¨tsklinikum Regensburg,
Ethikkommission der medizinischen Fakulta¨t, proposal 08/119).
Donors were fully informed of the possible complications and gave
their written consent for the procedure. Blood cells were collected
by leukapheresis in a Spectra cell separator (Gambro BCT, CO,
USA) followed by subsequent counterflow elutriation as described
elsewhere [19]. In brief, cells were elutriated in the following
order: platelets, lymphocytes, monocytes and then granulocytes.
Aliquots of the different cell fractions were analyzed for cell purity
on a BD FACSCanto flow cytometer (Becton Dickinson) using BD
FACSDiva Software. Cell numbers were determined on an
ADVIA 120 automated cell counter (Siemens Healthcare Diag-
nostics GmbH, Germany). Elutriated monocytes were then seeded
at a concentration of 16106 cells/ml in serum-free macrophage
medium (Invitrogen) that was supplemented with 50 ng/ml of
recombinant human macrophage colony-stimulating factor (rhM-
CSF, R&D Systems). 16107 cells per dish were cultured in 10 cm
Cell+ plastic petri dishes (Sarstedt) for RNA isolation and 26106
cells per well in Cell+ 6-well plates (Sarstedt, USA) for triplicates in
mass spectrometry. Incubation was performed at 37uC in a
humidified atmosphere containing 5% CO2 in an incubator. After
washing with PBS, the cell pellets were stored at 280uC. Protein
concentrations were measured according to Smith et al. [20] using
the BCA Assay from Uptima-Interchim (France) with serial
dilutions of bovine serum albumin as standard.
In vitro differentiation of HL-60 cells
HL-60 cells (ATCC; CCL-240) were grown in an incubator at
37uC (95% humidity, 5% CO2) in Iscove’s Modified Dulbecco’s
Medium (IMDM) (PAN-Biotech) containing 20% FBS (Biochrom)
in polystyrene tissue culture flasks (Sarstedt). Cells were seeded at a
density of 0.36106 cells per ml and 50% of the medium was
replaced once per week. Confluent cultures were split 1:3 to 1:4
once per week.
Differentiation experiments were performed in Cell+ tissue
culture flasks (Sarstedt). 1 mM working solutions of Vitamin D3
(VitD3)and all-trans retinoic acid (ATRA) were prepared in
ethanol. Cells were seeded at 0.36106 cells per ml. Monocytic
differentiation was achieved in macrophage serum-free medium
(SFM) supplemented with M-CSF (50 ng/ml) and 0.5 mM VitD3.
Granulocytic differentiation was carried out in macrophage SFM
with GM-CSF (10 ng/ml) and 0.5 mM ATRA. Cells grown in the
respective medium containing 0,05% ethanol were used as
controls. Cells were harvested by scraping with a rubber
policeman and centrifugation for 5 min at 500 g at room
temperature. They were finally washed once with PBS. Cell
number was determined by counting in a Casy automated cell
counter (Roche). Differentiation phenotype and viability were
monitored by flow cytometry and Pappenheim staining. Experi-
ments were repeated in two biological replicates.
Gene expression studies
Cells from nine donors were harvested, washed in PBS,
resuspended in buffer RLT and RNA was isolated using the
RNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. Purity and integrity of the RNA were determined
Figure 2. Schematic representation of fatty acid synthesis pathways. Fatty acid synthesis in the differentiation of primary human monocytes
shows an induction of enzymes involved in the synthesis of palmitate (FAS), desaturation (SCD, D5D and D6D) and elongation (ELOVL5 & 6). Blue
indicates significantly downregulated transcript levels, upregulated transcripts are shown in red and unchanged levels or unknown regulation in
shown in grey.
doi:10.1371/journal.pone.0094102.g002
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on the Agilent 2100 Bioanalyzer with the RNA 6000 Nano
LabChip reagent set (Agilent Technologies). RNA was quantified
using a Nanodrop ND-1000 - UV/Vis spectrophotometer
(PeqLab).
For gene array analysis we used a modified Agilent 4644K
microarray (014850) containing 205 free positions (Agilent
Technologies). To these positions we added 201 probes, corre-
sponding to 119 genes of the lipidome (LipidomicNet). 300 ng of
total RNA were labeled with Cy3 using the Agilent Quick-Amp
Labeling Kit - 1 color according to the manufacturer’s instruc-
tions. cRNA was purified with the RNeasy Mini Kit (Qiagen). The
amount and labeling efficiency of cRNA was measured with the
NanoDrop ND-1000. For hybridization the Agilent Gene
Expression Hybridisation Kit was used and arrays were incubated
in Agilent SureHyb chambers for 17 hours in a hybridization oven
at 65uC while rotating. Washing was performed according to the
manufacturer’s instructions. Scanning was done with the Agilent
G2565CA Microarray Scanner System. The resulting TIFF files
were processed with Agilent Feature Extraction software (10.7).
Microarray data are available in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) under accession number E-MTAB-2298.
Lipid mass spectrometry
Cell pellets were dissolved in 0.2% SDS solution. An aliquot
corresponding to 100 mg was used for mass spectrometric lipid
analysis. Lipid extraction was performed according to the method
of Bligh and Dyer [21] in the presence of not naturally occurring
lipid species as internal standards and the chloroform phase was
dried in a vacuum centrifuge and dissolved in 10 mM ammonium
acetate in methanol/chloroform (3:1 vol/vol). Samples were
analyzed by ESI-MS/MS in positive ion mode by direct flow
injection using the analytical setup and data analysis algorithms
described previously by Liebisch et al. [22]. PE-based plasmalo-
gens were quantified according to the principles described by
Zemski Berry and Murphy [18]. For this purpose fragment ions of
m/z 364, 380 and 382 were used for PE P-16:0, PE P-18:1 and PE
P-18:0 species, respectively. After identification of relevant lipid
species, selected ion monitoring analysis was performed. Material
from all thirteen donors was analyzed for differentiation days 1, 4
and 5. 0d monocytes were additionally available from four donors.
Lipid nomenclature is used as recommended in [23].
Statistical analysis
Partial least squares discrimination analysis (PLS/
DA). Partial least square discrimination analysis was performed
Figure 3. Regulation of PE plasmalogens during monocyte-macrophage differentiation. (A) Levels of total plasmalogens over thre course
of 5 day primary monocyte macrophage differentiation. Individual PE plasmalogen species show specific changes during differentiation (B and C).
Saturation specificity relative to day 0 is shown in panel (D).
doi:10.1371/journal.pone.0094102.g003
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and VIP values were calculated as described in [24–26]. The
computation was performed using SPSS 20 (IBM) with the PLS
extension module version 1.0.5 (IBM) under Python 2.7 with SciPy
0.11.0 (MLK) and NumPy 1.6.2 (MKL) on a 64 bit Windows 7
system (Microsoft).
Correlation analysis. Correlations between lipid species
were calculated in SPSS 20 (IBM) using Pearson’s product
moment correlational analysis.
Evaluation of Agilent microarray data. Microarray exper-
iments were analyzed according to the method described by
Kondrakhin et al. [27]. With this method for each gene a so called
hypergeometric score is calculated that considers the relative
changes of an mRNA as well as the absolute signal intensity of the
mRNA probe. Therefore relevant changes in gene expression can
be identified more easily. Transcripts with calculated values ,24
or .+4 were considered significantly regulated. Gene Ontology
enrichment analysis was performed on a ranked set of transcripts
from microarray data with the BioUML software platform. For
visualization only level 4 and level 5 categories were considered,
primarily lipid related categories were chosen for visualization.
In silico transcription factor prediction. Significantly
expressed and regulated lipid related genes were subjected to
transcription factor and virtual promoter analysis, predicting
potential transcriptional regulators. In silico promoter analysis was
carried out using the TRANSFAC database and the ExPlain
software system (BioBase, Germany). For in silico analysis we
focused on regions of 1000 bp upstream from the transcription
start site, and used a threshold in order to minimize false positive
errors.
Partial correlation and trancriptional network
visualization. q-order partial correlation graphs (qpgraphs)
were used to reverse engineer the molecular regulatory network
from microarray and lipid data. All data was Z-transformed prior
to analysis and average non-rejection rates (NRR) were calculated
in R 2.15.3 [28] using the package qpgraph [29–31]. The NRR
ranges from 0 to 1 and helps in deciding what edges are present or
missing from a qpgraph. In our experiments a threshold value of
0.3 was used for the non-rejection rate. The resulting network was
visualized in the editor yEd 3.12 (yWorks, Germany).
Results and Discussion
Adaptions in the lipid related transcriptome enable
monocytes for their phagocytic and inflammatory
function
Changes in the transcriptional profile during monocyte to
macrophage differentiation were analyzed using microarrays for a
comprehensive analysis of the cellular transcriptome at days 1, 4
and 5 of MCSF dependent in vitro differentiation. In total 4728
transcripts (34,1%) showed significant changes as indicated by a
hypergeometrical score of ,24 or .+4 between days 1 and 4 of
differentiation. Gene Ontology (biological process) analysis of the
genearray data showed that lipid metabolism is among the most
strongly positively enriched categories (Figure 1 and table S1). This
is in line with our previously published results showing the
importance of SREBP1/SP1 and SRF target genes in the
differentiation process [17]. In the current study we therefore
focused in depth on the regulation of genes involved in lipid
metabolism, analyzed the lipidomic pattern by mass spectrometry
and performed a bioinformatics analysis to study underlying
regulatory mechanisms.
Fatty Acid Metabolism. Fatty acids are carboxylic acids
with a long aliphatic tail. They are synthesized from acetyl-CoA
and malonyl CoA precursors via six recurrent reactions that are
catalyzed by the enzyme fatty acid synthase (FAS) until the 16-
carbon product palmitic acid (C16:0) is produced. The main
function of FAS is therefore to catalyze the synthesis of palmitate
from acetyl-CoA and malonyl-CoA, in the presence of NADPH.
The resulting saturated fatty acids are consecutively desaturated by
desaturases or elongated by elongases at the endoplasmic-
reticulum (ER). An overview over this process is given in
Figure 2 with enzymes that were upregulated on the mRNA level
shown in red and downregulated transcripts shown in blue. In our
differentiation model transcripts for FAS were upregulated
between days 1 and 4 and then remained stable at this level up
to day 5, potentially leading to an increased synthesis of fatty acids.
While the majority of cellular fatty acids that is synthesized via this
pathway have a length of 16 to 18 carbon atoms, the cell also
posseses the ability to elongate the carbon chain further using the
ELOVL family of proteins. They catalyze the rate limiting
condensation step in long chain fatty acid synthesis. ELOVL1 is
ubiquitously expressed and catalyzes the condensation of very long
chain (.C24) saturated or monounsaturated fatty acids [32].
During monocyte-macrophage differentiation, transcripts for
ELOVL1 were downregulated. On the other hand transcripts
for ELOVL5 and ELOVL6 were strongly induced. ELOVL5
processes a multitude of fatty acids including palmitoleic (C16:1, n-
7), oleic (C18:1, n-9), c-linolenic (C18:3, n-6), stearidonic (C18:4,
n-3), arachidonic (C20:4, n-6) and eicosapentaenoic acid (EPA,
C20:5, n-3) [33]. Adenoviral overexpression of ELOVL5 in
primary rat hepatocytes has been reported to increase the
elongation of arachidonic acid (20:4,n-6) and eicosapentaenoic
acid (20:5,n-3) into adrenic acid (22:4,n-6) and docosapentaenoic
acid (DPA, 22:5,n-3) respectively [34]. The monounsaturated fatty
acids palmitic (16:0, preferentially) and palmitoleic acid (16:1) acid
can be further elongated by ELOVL6 to stearic acid (18:0) and
oleic acid (18:1) [35,36]. During phagocytic differentiation
transcripts for ELOVL6 were only transiently upregulated on
day 4 and dropped again on day 5. Additionally ELOVL6 is
responsible for the elongation of C12 to C16 saturated and
monounsaturated long chain fatty acids [36]. Furthermore
peroxisomal trans-2-enoyl-CoA reductase was also strongly
induced and is known to play a role in chain elongation of fatty
acids, as well as estradiol 17-beta-dehydrogenase 12, an enzyme
that also has 3-ketoacyl-CoA reductase activity suggesting a role in
long fatty acid elongation. Transcripts for 3-hydroxyacyl-CoA
dehydratases 1 and 3 were upregulated. These enzymes are
responsible for the dehydration step in very long-chain fatty acid
(VLCFA) synthesis [37].
Desaturases introduce double bonds between defined carbon
atoms in fatty acyl chains. In humans four types of fatty acid
desaturases could be identified, according to the position of the
double bond introduced. In our experiments all analyzed fatty acid
desaturases were upregulated with the notable exception of
FADS3, which is interesting since the gene encoding FADS3 is
clustered with FADS1 and FADS2 [38]. The conversion of
palmitic acid (16:0) to palmitoleic acid (16:1), as well as the
conversion of stearic acid (18:0) to oleic acid (18:1) is mediated by
delta-9-desaturase (D9D), also called stearoyl-CoA desaturase-1
(SCD1) or FADS5. In this study the expression of this rate-limiting
microsomal enzyme was found to be strongly upregulated during
phagocytic differentiation of monocytes. The monounsaturated
fatty acids produced by SCD are further used as substrates in the
production of cholesteryl esters, triglycerides, phospholipids and
wax esters (reviewed in [39]). FADS1 (D5D), as well as FADS2
(D6D) are enzymes that are required for the synthesis of omega-3
and omega-6 long-chain polyunsaturated fatty acids. They
therefore play a role in the synthesis of arachidonic acid as a
Plasmalogens during Macrophage Differentiation
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precursor molecule for eicosanoid biosynthesis in omega-6 fatty
acid synthesis and in the omega-3 line of EPA and DHA
production. FADS1 is a delta-5-desaturase and FADS2 a delta-6-
desaturase. Delta-4 desaturases primarily play a role in sphingo-
lipid metabolism and were not significantly regulated by differen-
tiation.
The mitochondrial very long-chain specific acyl-CoA dehydro-
genase (ACADVL) was strongly up-regulated. Its function is the
degradation of very long fatty acids by catalyzing the first step of
the mitochondrial fatty acid beta-oxidation pathway. It can
accommodate substrates with chain lengths as long as 24 C-atoms
[40]. At the transcript level it was greatly diminished during
differentiation, indicating a decreased degradation of these long
chain fatty acids. On the other hand the dehydrogenase ACADSB
that is preferentially active on short and branched chain acyl-CoAs
was induced on days 4 and 5.
Lipoprotein Metabolism. Lipoproteins are aggregates of
apo-lipoprotein (apo) and lipid that allow the transport of lipids in
the aqueous blood stream. Especially plasmalogens are known to
correlate positively to serum HDL levels and to decrease with
aging [41]. During monocyte-macrophage differentiation apoE
was strongly induced. ApoE is important for metabolizing
triglyceride rich lipoproteins, is involved in vascular remodeling
[42] and has been described to be antiatherogenic and to mediate
cholesterol efflux. It also plays a role in the immune function of
macrophages. Apolipoprotein J/clusterin is involved in cholesterol
export from foam cells [43]. Its transcript levels were strongly
increased after differentiation. Apolipoprotein C-I and C-II were
also strongly upregulated. ApoC-I in plasma is mainly bound to
VLDL, chylomicrons, and HDL [44]. In macrophages it has
recently also been described to be able to bind lipopolysaccharide
(LPS) [45]. ApoC-I regulates cholesterol and phospholipid efflux
and seems to be crucially involved in the development of
atherosclerotic lesions [46]. ApoC-II plays a role in the catabolism
of triglyceride-rich lipoproteins and is also found on macrophages
in atherosclerotic plaques [44]. It has the ability to activate
lipoprotein-lipase (LPL). LPL is the primary enzyme for the
hydrolysis of triacyl-glycerides in chylomicrons and VLDL. Its
transcript was upregulated. Although LPL promotes foam cell
formation and atherosclerosis [47], it is generally viewed as anti-
atherogenic [48]. Macrophage LPL together with its activator
protein apoC-II is thought to modulate macrophage inflammatory
capacity through release of n-3/n-6 fatty acids. Their increased
expression during differentiation reflects the increased inflamma-
tory capacity of the macrophage by being able to access fatty acids
for the synthesis of inflammatory mediators. Another enzyme
potentially complementing LPL in the hydrolysis of monoglycer-
ides is monoglyceride lipase (MGLL). It was found upregulated,
facilitating hydrolysis of intracellular triglyceride stores to fatty
acids and glycerol. The expression level of the transcript for the
LDL receptor (LDLR) was only slightly diminished on day 4 and
significantly downregulated on day 5, for the VLDL-receptor
(VLDLR) we found no changes in expression.
Accumulation of excess free cholesterol in macrophages
contributes to the development of atherosclerosis by stimulating
tumor necrosis factor-a (TNF-a) and interleukin-6 production
[49]. This leads to ER-stress and apoptosis [50]. In general
enzymes involved in SREBP2 dependent cholesterol biosynthesis
were downregulated while proteins involed in cholesterol export
were strongly induced. The levels of the transcripts for the rate-
limiting enzyme in cholesterol synthesis HMG-CoA reductase [51]
were unchanged on day 4 and downregulated on day 5. Also
transcript levels for squalene oxidase, as well as lathosterol oxidase
were downregulated on both days. Cholesterol export from
macrophages is largely mediated by the transporter ABCA1, but
also to a smaller extent by ABCG1 [52–54]. It was found to be
protective against cardiovascular disease and fulfill an anti-
inflammatory function [52,55,56]. Interestingly this role seems to
Figure 4. HL-60 model for monocyte and granulocyte differentiation. PE plasmalogen species in an in vitro model of monocytes and
granulocytes using HL-60 cells show higher levels of species containing highly unsaturated acyl residues (.4 double bonds) in monocytic
differentiation and higher levels of less unsaturated species (,4 double bonds), mono- or saturated species in granulocytic differentiation.
doi:10.1371/journal.pone.0094102.g004
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be independent of cholesterol transport. Its expression was strongly
induced by differentiation. The cytosolic acetoacetyl-CoA thiolase
(ACAT2), the main enzyme mediating esterification of cholesterol
in the liver [57] was downregulated on day 5.
Plasmalogens, Glycerophospholipids and Eicosanoid
Biosynthesis. Plasmalogens are ether glycerol-phospholipids
that are integral parts of the plasma membrane as well as storage
lipids for acyl residues and cellular anti-oxidants. Their synthesis
takes place in a non-redundant pathway in peroxisomes and at the
ER-membrane. Interestingly, although the macrophage is pre-
pared for an immune reaction, transcripts for enzymes in
plasmalogen synthesis remained mostly unchanged. The rate
limiting enzyme for this process, glyceronephosphate O-acyltrans-
ferase (GNPAT, also called DHAP-AT), was not regulated on the
transcriptomic level. The acyl residues in phosphatidyl-ethanol-
amine (PE) plasmalogens are taken from the cellular free fatty acid
pool. For this purpose the enzyme fatty acyl-CoA reductase 1
(FAR1) provides the long chain fatty alcohol by reduction of
saturated fatty acyl-CoAs in the peroxisomal membrane. During
monocyte-macrophage differentiation its mRNA was downregu-
lated. The resulting alcohols are then further processed by
alkyldihydroxyacetonephosphate synthase (AGPS/ADHAP-S) in
the peroxisome, an enzyme whose transcript was downregulated
on day 4 and increased on day 5. These findings are in agreement
with constant levels of total plasmalogens that were detected in
lipid mass spectrometry (Figure 3A).
Eicosanoids are inflammatory mediators that are synthesized in
macrophages from eicosapentaenoic acid (EPA, n-3), arachidonic
acid (AA, n-6), and dihomo-gamma-linolenic acid (DGLA, n-6)
[58,59]. Plasmalogens in the plasma membrane represent a major
reservoir for the storage of these precursors in mammalian cells
(reviewed in [11]). Hydrolysis of the ester-bond in the sn-2 position
is the first step in eicosanoid synthesis from precursor acyl residues
in plasmalogens. Phospholipase A2 isoforms constitue a large
family of enzymes specifically produced for this purpose. With the
exception of PLA2G4A all PLA2 and PLD isoforms that were
analyzed on the microarray showed either stable or increasing
expression levels for their mRNA, while the endoperoxide
synthases were downregulated. This points towards a tight
regulation of eicosanoid production and processing. PLA2 is
required for releasing precursor molecules for eicosanoid biosyn-
thesis from either phosphatidylcholine (PC, esters) or plasmalogens
(vinyl-ethers). Although plasmalogen specific PLA2 activity has
been decribed in the literature, this enzymatic activity could not be
associated with a specific isoform or transcript in the phospholi-
pase family [60].
Eicosanoid production is subsequently mediated by the PG-
endoperoxide synthases PTGS1 and PTGS2, also known as
Figure 5. Partial least squares discriminant analysis (PLS/DA) during the course of primary monocyte-macrophage differentiation.
While latent variable LV1 is able to discriminate between days 0/1 and days 4/5 of differentiation, LV4 can differentiate between days 4 and 5.
doi:10.1371/journal.pone.0094102.g005
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cyclooxigenases COX1 and COX2 [61]. Transcripts for both
enzymes were downregulated, reaching significance for PTGS1
and showing a trend for PTGS2 in the hypergeometrical score.
On the other hand arachidonate 5-lipoxygenase (ALOX5), and
leukotriene A4 hydrolase (LTA4H) were strongly induced.
In summary these changes in the gene expression profile reflect
the major alterations in lipid metabolism: increases in fatty acid
synthesis, elongation and desaturation as well as increased
cholesterol production, utilization and export from phagocytic
macrophages in comparison to blood monocytes. Since the
modulated release of inflammatory mediators is a key contribution
Figure 6. Molecular network graph of genes correlating to PE plasmalogens during primary monocyte-macropahge differentiation.
Plasmalogens are shown in the center (rectangles) and correlating transcripts are grouped around them (circles). Circle size represents the number of
connected nodes, line width the strength of the correlation and color the tyoe of regulation (upregulated in red, downregulated in blue). Central key
nodes can be identified that have a multitude of connections to other nodes.
doi:10.1371/journal.pone.0094102.g006
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of macrophages in the development and sustenance of atheroscle-
rotic plaques we next focused on an in depth examination of
plasmalogen lipidomics.
The PE plasmalogen profile matures during monocyte
macrophage differentiation
As already mentioned before plasmalogens regulate cell
membrane fluidity and represent cellular stores for the precursor
molecules of eicosanoid biosynthesis, mainly arachidonic acid
[11]. Cellular PE-plasmalogen content was analyzed in monocytes
and monocyte-derived macrophages at days 0, 1, 4 and 5 of an in
vitro differentiation protocol. In general plasmalogen species
containing AA in sn-2 position were most abundant. During the
course of monocyte to macrophage differentiation, total plasmal-
ogen levels did not change significantly (Figure 3A, p= 0.186,
independent samples Kruskal-Wallis test due to varying number of
experiments per time point). However, at the species level we
found specific alterations in the plasmalogen species composition
(Figure 3B and C). Especially minor plasmalogen species showed
saturation dependent changes in concentration. As shown in
Figure 3D, plasmalogen species containing poly-unsaturated
(PUFA, five or six double bonds) or saturated acyl residues were
typically downregulated while species with sn-2 bound residues
with one, two or three double bonds were largely upregulated.
Species containing AA (20:4) did not show significant variations in
their levels.
Clinically atherogenesis starts with increased deposition and
modification of LDL in the subendothelium. Subsequently
inflammatory cells such as monocytes are chemotactically
attracted and migrate into the vessel wall. There they secrete
reactive oxygen species (ROS) producing an environment with
high levels of oxidative stress, that also affects the deposited LDL
(reviewed in [62]). Interestingly LDL particles from obese
metabolic syndrome patients and type 2 diabetics showed changes
in their lipid composition that were similar to the changes we
observed during monocyte-macrophage differentiation. Low
density lipoprotein from obese subjects contained generally lower
levels of PE plasmalogens and decreased proportions of PUFA in
their cholesteryl esters, while saturated fatty acids (SFA) and
mono-unsaturated fatty acids (MUFA) proportions were increased.
Similarly LDL particles from type 2 diabetic patients contained
decreased PUFA, had an unchanged MUFA content and showed
increased SFA [63].
The PE plasmalogen pattern in human blood cells has been
reported by our group before [12]. Interestingly the changes in the
plasmalogen pattern during differentiation rendered a mature
macrophage more similar to a blood granulocyte than the original
monocyte. Since granulocytes represent fully mature cells from the
same myeloid lineage as monocytes we suspected a general mode
Table 1. Results of an in silico transcription factor binding motif analysis.
Up-regulated genes Down-regulated genes
GZF1 CHCH
LXR PPARG
TATA HIF2A
IRF ZBTB
ZNF148 ELF ETS
ATF CREB AP1
TFE ZFX
GKLF FKLF
USF CNOT3
FOX RNF96
MYCMAX
AHRARNTHIF
E2F
Up- and down-regulated genes
AP2
NFY
P53
SP1SP4
EGR
Motives that were enriched in the 1000 bp promoter region upstream of up-regulated lipid related genes are shown on the left, binding motives that were enriched in
promoters of down regulated genes on the right and motifs that were associated with up- and down-regulated genes at the bottom. Abbreviations (as used in the
Transfac database): AHRARNTHIF: aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator/hypoxia inducible factor, AP1: activator protein 1, AP2:
activating protein 2, ATF CREB: activating transcription factor/cAMP response element binding, CHCH: Churchill, CNOT3: CCR4-NOT transcription complex subunit 3,
E2F: E2F transcription factor, EGR: early growth response, ELF ETS: E74-like factor/E26 transformation-specific, FKLF: fetal b-like globin gene-activating Kru¨ppel-like
factor, FOX: forkhead box, GKLF: gut-enriched Kru¨ppel-like factor, GZF1: GDNF-inducible zinc finger protein 1, HIF2A: hypoxia-inducible factor 2a, IRF: interferon
regulatory factor, LXR: liver X receptor, MYCMAX: Myc/Max transcriptional complex, NFY: nuclear factor Y, p53: phosphoprotein p53, PPARG: peroxisome proliferator-
activated receptor-gamma, RNF96: RING finger protein 96, SP1SP4: specificity protein 1 and 4, TATA: TATA box, TFE: Transcription Factor E (Family), USF: upstream
transcription factor, ZBTB: zinc finger and BTB (broad complex, tramtrack, and bric-a`-brac) domain-containing, ZFX: zinc finger X-chromosomal protein, ZNF148: zinc
finger protein 148.
doi:10.1371/journal.pone.0094102.t001
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of regulation. In order to validate this pattern we used an in vitro
model of HL-60 cells. Dependent on the stimulus, the pro-
myelocytic cell line HL-60 can differentiate to a monocytic (Vit
D3) as well as granulocytic (all-trans retinoic acid, ATRA)
phenotype. We therefore analyzed the plasmalogen species pattern
of differentiating HL-60 cells (Figure 4) and performed correlation
analysis.
The correlation of HL-60 monocytic and granulocytic differ-
entiation was strongly positive (Pearson r = 0.960, p,0.001).
Furthermore we found a significant correlation between the
changes in monocyte to macrophage differentiation and the
regulation of plasmalogen species during monocytic differentiation
of HL-60 cells (Pearson r =20.522, p = 0.005). In contrast the
changes found in HL-60 derived granulocytic cells were statisti-
cally different from monocyte-macrophage differentiation (Pearson
r =20.359, p = 0.066).
Quantification of PE plasmalogen species allows
discrimination of the differentiation state in a partial least
squares discriminant analysis (PLS/DA)
Since the plasmalogen pattern undergoes very specific changes
during phagocytic differentiation we hypothesized that it could
serve as a biomarker for predicting the monocyte to macrophage
differentiation state. To this end a PLS/DA analysis was
performed on the data obtained from primary human monocytes
and macrophages. PLS is a mathematical method that allows to
analyze the influence of a matrix of predictors on an outcome
variable.
In this approach 4 different latent variables were computed and
plotted graphically to evaluate their power to differentiate the
differentiation stage. As shown in Figure 5, latent variable 1
allowed the clear discrimination of cells on days 0 and 1 from
more mature cells on days 4 and 5. On the other hand latent
variable 3 permitted to partially discern between days 4 and 5. A
distinction between day 0 and day 1 was not possible using this
approach. Therefore while there was no clear difference in the PE-
plasmalogen pattern between undifferentiated monocytes and
monocytes that had been treated with rhMCSF for 1d, cells that
had been cultured with M-CSF for 4 or 5 days were clearly
different in their lipidomic profile.
We also determined the most influential lipid species by
calculating so called Variable Importance for the Projection
(VIP) values as shown in Figure S1. The PE-plasmalogen species
that showed the strongest potential to discriminate between
monocytes and macrophages (mean PLS VIP 1) were minor
species containing docosapentaenoic acid (DPA, 22:5), docosahex-
aenoic acid (DHA, 22:6) and palmitoleic acid (16:1) esterified in
sn-2 position. On the other hand linoleic acid (18:2) containing
species were best in discerning between days 4 and 5 of
differentiation.
Chronic, systemic low-grade inflammatory diseases such as
diabesity and the metabolic syndrome are characterized by a
strong activation of tissue macrophages that chemotactically also
attract additional monocytes from the circulating blood stream
[64]. Therefore it is likely that such a chronic inflammatory
reaction will also be reflected in the plasmalogen pattern of plasma
samples or be detectable in isolated blood monocytes, rendering it
a potential lipidomic biomarker.
Transcriptional network analysis for the identification of
novel PE plasmalogen related key nodes
In order to identify novel players influencing the regulation of
cellular plasmalogens we performed partial correlation analysis of
plasmalogen species with gene array data (Figure 6). This
bioinformatic approach allows to reduce the complexity of the
model by eliminating indirect interactions and therefore to better
identify key nodes. Among the transcripts found to be central by
this algorithm were well known factors proving the plausibility of
the method. For example MAFB is a known inducer of monocytic
differentiation [65] that showed up centrally. Also the 70 kDa
heatshock proteins HSPA1B and HSPA1A were central nodes.
Hsp70 proteins act as molecular chaperones that can maintain the
survival of stressed cells [66–69]. They accomplish this by
stabilizing lysosomal membranes through the binding of BMP
[70]. For these proteins genotypic variations have been described
that play a role in cytokine release [71].
Furthermore a range of proteins that have not yet been
implicated in monocyte-macrophage differentiation were identi-
fied. DOCK1 is a Rac activator that regulates myoblast fusion
[72]. It is involved in regulating cell surface extensions and has the
ability to bind phospholipids via a DHR1 domain [73]. Thereby it
posseses the ability to interact with cell membranes, a function that
is essential for differentiated macrophages. In our cells its
transcript levels were significantly upregulated during the differ-
ention process. Pyruvate dehydrogenase lipoamide kinase isozyme
4 (PDK4) is a mitochondrial enzyme regulating glucose metab-
olism and therefore cellular energy homeostasis. Strongly
decreased expression of PDK4 as found in our analysis increases
metabolism and especially conversion of glucose to acetyl-CoA,
thereby improving substrate availability for fatty acid synthesis.
Moreover N-acetylglucosamine-1-phosphate transferase
(GNPTAB, significantly upregulated during differentiation) is
involved in synthesis of mannose-6-phosphate, that itself tags
hydrolases for transfer to the lysosome. The expression of this
enzyme could therefore have influence on the protein composition
of the macrophage lysosomes. The protein encoded by FAM126A
may play a part in the beta-catenin/Lef signaling pathway and has
not been described to play a role in macrophages before. In our
cells its mRNA levels were downregulated during differentiation.
C12orf48 enhances PARP-1 activity, protecting from DNA
damage [74], knockdown was anti-proliferative in HeLa cells
[75]. It was upregulated. Meiosis-specific nuclear structural 1
(MNS1, significantly upregulated) has only been described to play
a role in the regulation of meiosis before [76]. Its function in
monocytes and macrophages has not been analyzed yet.
Further transcripts that were identified include ARHGAP26, a
Rho GTPase involved in the formation of endocytotic vesicles, cell
spreding and adhesion [77], ACCN2, a sodium channel [78] and
KIAA1524, a phosphatase inhibitor that plays a role in
oncogenesis [79].
Further studies are needed to clarify the role of these potential
lipid related modulators of the differentiation process.
Identifying underlying transcription factors
Major regulatory changes in the cellular transcriptional profile
are mediated by transcription factors. We used a bioinformatics
approach therefore affecting all target genes that contain a specific
binding motif in their promoter region at the same time. This
search was based on transcripts listed in the Gene Ontology
category lipid metabolism. Transcription factors that are predicted
to bind to promoters of these genes are shown in Table 1. On the
one hand this approach predicted well known factors essential in
macrophage differentiation such as PPARG, KLF4 [80] and
EGR1 [81,82] proving the feasibility of the algorithm. The
binding motifs identified in this approach also allow binding of
previously described factors that regulate lipid associated genes
such as SREBP1, although it does not show up in the analysis
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directly. SREBP1 is known to interact with Sp1 at Sp1/Sp4 sites in
regulating gene expression, as well as with Nuclear factor Y (NFY).
Therefore combinations of these factors determine the regulation
of distinct cellular pathways [83]. SREBP1 target genes include
fatty acid synthase and the LDL-receptor. Transcript levels for
both were strongly induced during the differentiation process.
SREBP1 also posses the ability to cooperate with CREB-binding
protein as a co-activator. This combinatorial regulation of multiple
transcription factors is also likely to be the reason for the
occurrence of the motifs for EGR and p53 in up- and
downregulated genes at the same time. On the other hand an
involvement of previously not published binding motives could be
predicted for the first time. These include ZNF148, nuclear factor
Y and RNF96. Since transcription factor binding motif analysis
was based solely on lipid metabolism related transcripts, it is likely
that some of the known effects of these transcription-factors on
differentiation are mediated in turn by lipidomic changes in the
cell.
Summary and Conclusion
During the differentiation process to mature macrophages
monocytes undergo profound changes in their lipidomic and
transcriptomic profile to prepare them for their phagocytic and
inflammatory function.
Fatty acid synthesis pathways show a strong induction of
transcripts involved in fatty acid desaturation and elongation.
Lipid transport and lipoprotein related transcripts are differentially
modulated partly in a pro-inflammatory way partly anti-inflam-
matory. On the one hand cholesterol biosynthesis is downregu-
lated and export is strongly promoted. At the same time the cell
prepares to facilitate the hydrolysis of triglycerides. In depth
analysis was perfomed for plasmalogens. Plasmalogen biosynthesis
pathways remained mostly unchanged on the mRNA level. This
was reflected in lipidomic measurements showing constant total
plasmalogen levels. Plasmalogens represent storage lipids for
precursor acyl-residues in eicosanoid synthesis. Transcripts for
the iso-enzymes involved in eicosanoid production were tightly
regulated.
Lipidomic analysis of PE plasmalogens showed decreases in
polyunsaturated species (PUFA) and increases in monounsaturated
species (MUFA). These adaptions rendered monocyte derived
macrophages more similar to mature granulocytes in their
plasmalogen profile. This observation could be confirmed in an
HL-60 model system for granulocytic and monocytic in vitro
differentiation. The PE plasmalogen species pattern could be
shown to be specific for monocytes and monocyte derived
macrophages permitting a purely lipidomic discrimination of the
differention stage. It might therefore also represent a potential
biomarker indicating immune system activation, e.g. in patients
with metabolic syndrome that suffer from chronic, low-grade
inflammation.
A bioinformatic approach using partial correlation and molec-
ular network reconstruction was able to identify novel potential
hubs in the plasmalogen related transcriptional network, such as
70 kDa heatshock proteins, DOCK1, PDK4, GNPTAB,
FAM126A, MNS1 and C12orf48. Further studies are currently
underway to clarify the potential modulatory role of these proteins
during differentiation. Transcription factor motif analysis revealed
the involvement of several binding motifs with the remarkable
involvement of motifs for NFY, P53, SP1 and EGR in up- and
down- regulated genes. Therefore probably the interplay of
multiple additional factors such as SREBP, determines the amount
of transcription of lipid regulatory transcripts.
In summary we could for the first time show the specificity of
the changes in the plasmalogen pattern during monocyte to
macrophage differentiation. Furthermore using a bioinformatics
approach we were able to predict novel regulatory hubs and
transcription factors that might play central roles in the complex
interplay of transcription-factors, transcripts and lipids during
monocyte-macrophage differentiation.
Supporting Information
Figure S1 Variable importance in projection for PE
plasmalogens during differentiation. The VIP value
summarizes the contribution a variable makes to the model.
Therefore higher values (especially values larger than 0.8) signify a
more significant contribution of the respective lipid species to the
estimation of the differentiation stage.
(TIF)
Table S1 GO classification of enriched transcripts
during differentiation. Normalized enrichment scores (NES)
were calculated to reflect the distribution of Gene Ontology
categories across a list of genes ranked by hypergeometrical score
(HGS). A higher enrichment score indicates a shift of genes
belonging to certain GO categories towards either end of the
ranked list, representing up or down regulation (positive or
negative values, respectively).
(XLSX)
Table S2 Hypergeometrical score of lipid related
transcripts during differentiation. Agilent microarray data
shows regulatory activity in fatty acid desaturation and elongation
as well as changes in plasmalogen synthesis and degradation.
Comparisons were made for day 4 versus day 1 (d4) and for day 5
versus day 1 (d5). Blue color indicates a significantly lower value
following differentiation while red indicates significantly higher
values.
(DOCX)
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